Bacterial Vaginosis Relief

Pivotal phase 3 clinical trials commenced for VivaGel® as a treatment for bacterial vaginosis In late March Starpharma was pleased to announce the commencement of two concurrent phase 3 clinical trials of VivaGel® for the treatment of bacterial vaginosis (BV).  

Bacterial vaginosis (BV) sounds like a big scary term ... but Planned Parenthood recommends that all women with BV symptoms visit their doctor for treatment to prevent rare but serious complications. Treatment for BV is usually as simple as a course ...  

That microbial problem results in matching signs as in bacterial contamination. Nevertheless, a discharge within the genitals is likely to be existing too. An prescription antibiotic treatment solution is adequate for stopping vaginosis. Treatments needs ...  

Researchers hope further study will lead to personalized medicine for women, allowing doctors to tailor each woman's treatment and health maintenance ... reduce misdiagnosis of conditions such as bacterial vaginosis, and unnecessary prescription of broad ...  

The research involving 1,000 women, commissioned by feminine health company Balance Activ, found one-quarter of British women will trust the Internet for advice on treatments if ... The study found Bacterial Vaginosis was being misdiagnosed by two out ...  

Announcements during the quarter included: • Receipt of final written agreement from the FDA on the design of the phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA's Special Protocol Assessment (SPA ...  

Researchers hope further study will lead to personalized medicine for women, allowing doctors to tailor each woman’s treatment and health maintenance ... misdiagnosis of conditions, such as bacterial vaginosis, and unnecessary prescription ...  

The researchers conducted a search for studies reporting malaria, syphilis, Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, or bacterial vaginosis among ... of intermittent preventive treatment during pregnancy (IPTp ...  

Shionogi anticipates Flagyl® will bring a new treatment option to patients and medical experts by the approval for bacterial vaginosis and is striving to make contributions to the resolution of the Unapproved Drugs and Off-label Drug Use.  

"This certainly changes the diagnosis, treatment and prevention of vaginosis (bacterial infection in the vagina)," said Stephen Dewhurst, chairman of microbiology and immunology at the University of Rochester Medical Center in New York.  

Treatment must be established as soon as possible (before the 12th week). Of course, all pregnant women with bacterial vaginosis will not develop complications.